HOME >> BIOLOGY >> NEWS
Humus/Mineral interaction

University Park, Pa. --- A group of Penn State-led researchers has shown that, for some fossil fuel-based pollutants, increasing the humus content of the soil increases, rather than decreases, the likelihood that the contaminant will move to ground water.

Dr. Jon Chorover, assistant professor of environmental soil chemistry, says, "The general belief is that, as you increase the organic matter in soil, you increase the retention of contaminants. We found that that is not always the case. It depends on the nature of the compound."

Chorover and his colleagues at Penn State's Environmental Resources Research Institute and Ohio State University looked at quinoline, a nitrogen heterocyclic compound (NHC), that has been little studied to date. Quinoline belongs to the broad group of environmental contaminants, termed ionizable PACs (polycyclic aromatic compounds), often found in sites polluted by fossil fuels, solvents, greases, creosote and coal tar.

They found that if a soil is low in organic matter, quinoline is more likely to become strongly bound to the soil and less likely to move to ground water. However, in its strongly bound state, the pollutant is also less likely to be broken down by microrganisms.

The researchers detail their results in the just released current issue of the Soil Science Society of America Journal in a paper, "Quinoline Sorption on Kaolinite-Humic Acid Complexes."

Chorover's co-authors are Mary Kay Amistadi, research support associate in Penn State's Department of Agronomy; Dr. William D. Burgos, Penn State assistant professor of civil and environmental engineering; and Dr. Patrick G. Hatcher, professor of environmental chemistry, Ohio State University.

The study also shows that mineral interactions with humus were key to whether quinoline was retained in soil. When humic substances coated the mineral phase, quinoline was less likely to adhere. However, when the min
'"/>

Contact: Barbara Hale
bah@psu.edu
814-865-9481
Penn State
27-Sep-1999


Page: 1 2

Related biology news :

1. New technique helps scientists reveal interactions between genes and drugs
2. Rutgers chemist uses NMR to elucidate protein-DNA interaction
3. Findings suggest need for new view of p53 cancer proteins interaction with DNA
4. A pregnant pause for unexpected interactions
5. Butterflies & the hormonal basis of interactions between life histories & morphology
6. Seeing the forest for the trees: The future of environmental policy lies in interaction
7. Gene interactions control circadian clock in plants, study finds
8. Ability to smell food regulated by enzymes interaction with RNA interference pathway
9. Close interaction seen between blood vessel development and fat tissue formation
10. Unzipping double helix to study protein-DNA interaction
11. Invariant properties in coevolutionary networks of plant-animal interactions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Humus Mineral interaction

(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... , ... July 29, 2015 , ... The third Medical ... combination products , in particular, drug/device combinations. The current system received a score ... Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi ... Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in ... core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... Costello ... new levee system to protect the Orange County, Texas area from future storm ... multi-firm design team in determining several potential levee alignment alternatives for providing protection, Costello ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2
Cached News: